THNR vs. AGNG
THNR (Amplify Weight Loss Drug & Treatment ETF) and AGNG (Global X Aging Population ETF) are both Health & Biotech Equities funds - THNR tracks the VettaFi Weight Loss Drug & Treatment Index while AGNG tracks the Indxx Aging Population Thematic Index. Both are passively managed. Over the past year, THNR returned 9.10% vs 9.81% for AGNG. A 0.75 correlation means they provide meaningful diversification when combined. THNR charges 0.59%/yr vs 0.50%/yr for AGNG.
Performance
THNR vs. AGNG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THNR achieves a -5.20% return, which is significantly lower than AGNG's -4.79% return.
THNR
- 1D
- -1.47%
- 1M
- -2.91%
- YTD
- -5.20%
- 6M
- -3.73%
- 1Y
- 9.10%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
AGNG
- 1D
- 0.41%
- 1M
- -2.10%
- YTD
- -4.79%
- 6M
- -5.36%
- 1Y
- 9.81%
- 3Y*
- 8.25%
- 5Y*
- 3.96%
- 10Y*
- 8.76%
THNR vs. AGNG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
THNR Amplify Weight Loss Drug & Treatment ETF | -5.20% | 13.65% | -10.36% |
AGNG Global X Aging Population ETF | -4.79% | 20.01% | 0.90% |
Correlation
The correlation between THNR and AGNG is 0.77, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.77 |
Correlation (All Time) Calculated using the full available price history since May 22, 2024 | 0.75 |
The correlation between THNR and AGNG has been stable across timeframes, ranging from 0.75 to 0.77 - a consistent structural relationship.
THNR vs. AGNG - Sectors Allocation Comparison
Sectors
THNR
AGNG
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
Technology
-
-
Utilities
-
-
Healthcare
THNR
AGNG
Financial Services
THNR
AGNG
-
Basic Materials
THNR
-
AGNG
-
Communication Services
THNR
-
AGNG
-
Consumer Cyclical
THNR
-
AGNG
-
Consumer Defensive
THNR
-
AGNG
-
Energy
THNR
-
AGNG
-
Industrials
THNR
-
AGNG
-
Real Estate
THNR
-
AGNG
Technology
THNR
-
AGNG
-
Utilities
THNR
-
AGNG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THNR vs. AGNG — Risk / Return Rank
THNR
AGNG
THNR vs. AGNG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Global X Aging Population ETF (AGNG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| THNR | AGNG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.48 | 0.72 | -0.25 |
Sortino ratioReturn per unit of downside risk | 0.81 | 1.12 | -0.31 |
Omega ratioGain probability vs. loss probability | 1.10 | 1.13 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 0.76 | 0.86 | -0.10 |
Martin ratioReturn relative to average drawdown | 1.75 | 2.34 | -0.60 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| THNR | AGNG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.48 | 0.72 | -0.25 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.26 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.53 | -0.62 |
Drawdowns
THNR vs. AGNG - Drawdown Comparison
The maximum THNR drawdown since its inception was -32.51%, which is greater than AGNG's maximum drawdown of -30.58%. Use the drawdown chart below to compare losses from any high point for THNR and AGNG.
Loading charts...
Drawdown Indicators
| THNR | AGNG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.51% | -30.58% | -1.93% |
Max Drawdown (1Y)Largest decline over 1 year | -12.06% | -11.45% | -0.61% |
Max Drawdown (3Y)Largest decline over 3 years | — | -14.48% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.66% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -30.58% | — |
Current DrawdownCurrent decline from peak | -13.00% | -11.09% | -1.91% |
Average DrawdownAverage peak-to-trough decline | -12.24% | -5.95% | -6.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.26% | 4.20% | +1.06% |
Volatility
THNR vs. AGNG - Volatility Comparison
Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.16% compared to Global X Aging Population ETF (AGNG) at 3.87%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than AGNG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THNR | AGNG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.16% | 3.87% | +1.29% |
Volatility (6M)Calculated over the trailing 6-month period | 13.55% | 10.00% | +3.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.15% | 13.62% | +5.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.37% | 15.22% | +4.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.37% | 17.13% | +2.24% |
THNR vs. AGNG - Expense Ratio Comparison
THNR has a 0.59% expense ratio, which is higher than AGNG's 0.50% expense ratio.
Dividends
THNR vs. AGNG - Dividend Comparison
THNR's dividend yield for the trailing twelve months is around 1.73%, more than AGNG's 0.92% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
AGNG Global X Aging Population ETF | 0.92% | 0.88% | 0.83% | 0.96% | 0.49% | 0.72% | 0.36% | 0.83% | 1.00% | 1.04% | 0.45% |
THNR Amplify Weight Loss Drug & Treatment ETF | 1.73% | 1.64% | 0.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
THNR and AGNG have a correlation of 0.77, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
THNR has higher volatility (5.16%) compared to AGNG (3.87%). In terms of maximum drawdown, THNR dropped -32.51% vs AGNG's -30.58%.
On 1-year performance, AGNG leads with 9.81% vs 9.10% for THNR. On fees, AGNG is cheaper at 0.50% per year. On volatility, AGNG has been the lower-risk option at 3.87%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, AGNG has performed better with a 9.81% return vs 9.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
AGNG is cheaper with a 0.50% expense ratio, compared with 0.59% for THNR.
THNR has the higher dividend yield at 1.73%, compared with 0.92% for AGNG.
THNR tracks VettaFi Weight Loss Drug & Treatment Index, while AGNG tracks Indxx Aging Population Thematic Index. They also come from different issuers: Amplify and Global X. Their fees differ too: 0.59% for THNR and 0.50% for AGNG.
AGNG currently has the higher Sharpe Ratio (0.72 vs 0.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THNR and AGNG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer